Miriplatin (hydrate)

SKU: orb1705148

Description

Miriplatin hydrate (SM-11355) is a lipophilic platinum complex designed for transarterial chemoembolization (TACE) in hepatocellular carcinoma research. Its formulation in Lipiodol allows sustained local release of active platinum species, facilitating studies on targeted drug delivery and cytotoxicity in both in vitro and in vivo experimental models.

Research Area

Molecular Biology

Key Properties

• CAS Number: 250159-48-9
• MW: 782.01
• Purity: 99.60% (May vary between batches)
• Formula: C₃₄H₇₀N₂O₅Pt
• SMILES: CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O.N[C@H]1[C@H](N)CCCC1.O.[Pt+2]
• Target: DNA Alkylation
• Solubility: DMSO:< 1 mg/mL (insoluble or slightly soluble);H2O:Insoluble

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Miripla, Miriplatin, Miriplatin hydrate, Miriplatin Hydrate, DNA Alkylation, DNA alkylator, DNAAlkylation, SM 11355, SM11355, SM-11355, SM-11355 (hydrate)

Compound Identifiers

PubChem CID

23725065